Haematological Malignancies Completed Phase 1 Trials for ABT-751 (DB12254)

Also known as: Hematological Malignancies / Hematological Malignancy / Haematological Malignancy / Hematologic malignancy / Hematologic Neoplasms

IndicationStatusPhase
DBCOND0046524 (Haematological Malignancies)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00047489Study of ABT-751 in Patients With Refractory Hematologic MalignanciesTreatment